BOULDER, Colo.--(BUSINESS WIRE)--Jul. 26, 2016--
Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its second quarter
2016 financial results on Monday, August 8, 2016, after the close of the
U.S. financial markets. Clovis’ senior management will host a conference
call and live audio webcast at 4:30 p.m. ET that day to discuss the
company’s results in greater detail.
The conference call is being webcast and can be accessed from the Clovis
Oncology website at www.clovisoncology.com.
A replay of the webcast will be available for 30 days.
About Clovis Oncology
Clovis Oncology, Inc. is a biopharmaceutical company focused on
acquiring, developing and commercializing innovative anti-cancer agents
in the U.S., Europe and additional international markets. Clovis
Oncology targets development programs at specific subsets of cancer
populations, and simultaneously develops diagnostic tools that direct a
compound in development to the population that is most likely to benefit
from its use. Clovis Oncology is headquartered in Boulder, Colorado.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160726006235/en/
Source: Clovis Oncology
Breanna Burkart, 303-625-5023